Role of early intervention of Ayurveda in Hepatitis-A - A Case Study

Keywords: Bilirubin, Hepatitis-A, Kamala, Virechana

Abstract

Hepatitis A is the inflammation of the liver caused by the Hepatitis-A virus. 1.5 million clinical cases are recorded annually worldwide and are responsible for 15,000 to 30,000 deaths per year.[1] Acute viral hepatitis (AVH) has resemblance with Kamala mentioned in Ayurveda. Kamala is a disease of the Rakta Dusti and Pitta Prakopa. Virechana with Mridu and Tiktaka drugs along with wholesome diet is the principle to treat the condition in Ayurveda. A 20-year-old male diagnosed with hepatitis-A treated in accordance to the Ayurvedic principles, that is, Mridu Virechana and Pitta Samana. The total duration of the treatment is for 30 days. In this case, a complete remission of symptoms with a substantial reduction in bilirubin and hepatic enzymes observed following Ayurvedic treatment.

Downloads

Download data is not yet available.

References

Mohan H. Textbook of Pathology. 6th ed. New Delhi: Jaypee Brothers; 2010. p. 606.

Nelson. Essentials of Pediatrics. 8th ed. Philadelphia: Elsevier; 1990. p. 1681.

Davidson. Davidson’s Medicine. 19th ed. Edinburgh: Elsevier Science Limited; 2004. p. 862.

Munjal YP. API Textbook of Medicine. Vol. 1. 10th ed. New Delhi: Jaypee Brothers Publishers; 2015. p. 1167-74.

Ramasastry V. Charaka Samhita Chikitsa Sthanam. 16:34-36. Vavilla Ramasastry and Sons; 1931. p. 732.

Ramasastry V. Charaka Samhita Chikitsa Sthanam. 16:40. Vavilla Ramasastry and Sons; 1931. p. 734.

Ramasastry V. Charaka Samhita Chikitsa Sthanam. 16:42. Vavilla Ramasastry and Sons; 1931. p. 734.

Ramasastry V. Charaka Samhita Chikitsa Sthanam. 16:114. Vavilla Ramasastry and Sons; 1931. p. 754.

Ramasastry V. Charaka Samhita Chikitsa Sthanam. 16:115. Vavilla Ramasastry and Sons; 1931. p. 755.

Sharma PV. Dravya Guna Vigyana. Vol. II. Reprint. Varanasi: Chaukhamba Visvabharthi; 2009. p. 640.

Ramasastry V. Charaka Samhita Chikitsa Sthanam. 4:50. Vavilla Ramasastry and Sons; 1931. p. 734.

Zanwar AC, Wajpeyi SM. Management of Hepatitis B (Carrier stage) through Ayurveda – A Case report. Int J Ayur Med. 2020;10(4):342–344.

Kumar G, Srivastava A, Sharma SK, Gupta YK. Safety evaluation of an Ayurvedic medicine, Arogyavardhini vati on brain, liver and kidney in rats. J Ethnopharmacol. 2012;140:151–60.

Variers PS. Vaidyaratnam Indian Medicinal Plants. Vol. 4. Arya Vaidya Sala, Kottakal; 2000. p. 172-179.

Evaluation of Hepatoprotective Efficacy of Polyherbal Formulation “Amlycure DS” on Anti-Tubercular Drug (ATT) Induced Hepatotoxicity. Asian J Biochem Pharm Res. 2015; Issue 3(Vol. 5). ISSN: 2231-2560 CODEN (USA): AJBPAD.

CITATION
DOI: 10.21760/jaims.10.3.62
Published: 2025-05-17
How to Cite
1.
Rajani Pydi, Tulasidas Pandiri. Role of early intervention of Ayurveda in Hepatitis-A - A Case Study . J Ayurveda Integr Med Sci [Internet]. 2025May17 [cited 2025May22];10(3):403 -406. Available from: https://www.jaims.in/jaims/article/view/4171
Section
Case Report